Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans... see more

TSXV:NU.H - Post Discussion

View:
Post by geodcan on Aug 12, 2021 12:27pm

It's alive!

At least somebody burned a calorie or two to fluff out a nr!

So much multi-bagger potential with this if he can deliver.  I would like to see stoking the fire on the Tabletz before we go chasing other stuff.  I like the drink plan but know what is required and the failure rate of this type of sku.  Can Japan launch drinks too with their approval for the Tabletz?  Sounds like there wouldn't be much competition in Japan for that type of sku if they are keeping the lid on as tight as we are led to believe for cannabinoids.

glta and dyodd
Comment by Edcando on Aug 12, 2021 1:04pm
I asked myself the same question and I honestly don't know the answer. I guess maybe I should ask Glen next time I email. The way I see it is IF the drink product uses the same ingredients (amounts included) and IP and is only changing the delivery system (or it's a drink not a tab) then approval should be easy/fast it already approved. Again I don't know it's just a guess. I also ...more  
Comment by CaptainCrunchy on Aug 14, 2021 9:47pm
I wish there had been some mention of the initial order and the progress on that in NR, pretty dissapointing it seemed pretty fluffy again. Seemed something vould have been said to be clearer about the order. Probably look at near 2 weeks for that webinar, which seems a while to wait for more clarity on what seems like a past due order. It is nice that Q&A webinar is going to be done, it ...more  
Comment by Edcando on Aug 15, 2021 1:16pm
Yeah I can't even really call that NR an NR LOL, but I guess it was an update (that they'll be telling us more the week of the 23rd). All the waiting sucks , but there's no way to know if it's a past due order since we have no idea what the delay is. Could go with way with this webinar or whatever it is. I guess there is a chance we get some definitive news before it (a lot more ...more  
Comment by CaptainCrunchy on Aug 15, 2021 9:04pm
It did sound like it's at the tabletz end of things. Reading between the lines in NR, seemed like they are waiting for a fully complete roll out plan at that end, hoping they will have that information by 23rd. So new will know more when Tabletz has worked out it strategy after all the sales numbers from Biople have been considered and how all those players are going to go about things. So ...more  
Comment by lscfa on Aug 16, 2021 12:16am
The co. has never said it would alert shareholders when the big order would be shipped. It could be in Japan already. The first-to-market period with Biople must conclude before the big order can be distributed to Japanese stores. It's been < 60 days since Biople received its rush order. Neutrisci  should have disclosed how long the damn exclusive period was for.
Comment by Edcando on Aug 16, 2021 1:08am
Imo there's definitely been a delay. I think it was mentioned to be approx 1 month exclusivity but can't quite remember where I saw or heard that. Hoping for news before the webinar but expecting clarity during it. GLTUA 
Comment by CaptainCrunchy on Aug 16, 2021 6:24am
they would have told us when it was shipped, like the rush order and mention of it being in next financials. It 100% would have been a relevant NR they would have put out. It may have been one of those interviews or older NRs that mentionned biople getting 1month exclusive. Think maybe the NR about rush order, explaining why they needed it ASAP, while the initial was for everyone else. (Could have ...more  
Comment by lscfa on Aug 16, 2021 8:30am
Modifying the sticks order to sticks and bottles is a plausible reason for the delay.    
Comment by KelownaClown on Aug 16, 2021 6:39pm
So, Ed "thinks", but can't quite remember, hopes for news, expects clarity... like he says the only thing definite is the delay. Brilliant stuff. Thanks Ed. 
Comment by CaptainCrunchy on Aug 17, 2021 12:32am
not sure that volume was buying. Price took a dip and still more in ask than bid. Hope that isn't someone that already knows answers to our questions. Lol On another note. I am not overly concerned about the beverage and delta 9 stuff. It would be great but simply doing this initial few million and quarterly follow up orders would change everything. Would bring the beverage , delta 9 and ...more  
Comment by Edcando on Aug 17, 2021 12:41am
Yes the first volume was good buying . Then some sold into the bid but less than bought . Either way let's not get out of hand. Nice to see some buys and while higher than normal average lately  it wasn't that much volume lol.  Looking forward to some news and/or clarity . GLTUA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities